FDA recall D-1128-2018

Baxter Healthcare Corporation · Class II · drug

Product

0.9% Sodium Chloride Injection USP 100 mL bags, Rx only, Baxter Healthcare Corporation Deerfield, IL 60015 USA, NDC 0338-0049-18

Reason for recall

CGMP Deviations

Distribution

TX and MS only

Key facts

Status
Terminated
Initiation date
2018-08-21
Report date
2018-09-05
Termination date
2019-10-30
Voluntary/Mandated
Voluntary: Firm initiated
Location
Deerfield, IL, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1128-2018